It sounds like science fiction: people with end-stage liver disease are injected with cells from a donor liver and, in response, their body produces multiple mini livers that keep them healthy.
Yet, science fiction really could be on the verge of becoming scientific fact, because US company LyGenesis is about to begin clinical trials in which participants are expected to develop such “ectopic” livers.
